RxDoctor Payments DataLook up a doctor →

Kathryn Valazak

Psychiatric/Mental Health · Indiana, PANPI 1285267690

Payments from drug & device makers

$7,139in general payments, 2019–2025

Across 443 payments — averaging $16.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Neurocrine Biosciences, Inc.$704
  • Otsuka America Pharmaceutical, Inc.$592
  • Lundbeck LLC$331
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$328
  • plus $3K from 36 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie102$1,390
Teva Pharmaceuticals USA, Inc.103$1,254
Neurocrine Biosciences, Inc.39$704
Otsuka America Pharmaceutical, Inc.34$592
Lundbeck LLC18$331
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)16$328
Vanda Pharmaceuticals Inc.10$263
Alkermes, Inc.10$210
Novartis10$186
Sunovion Pharmaceuticals Inc.10$173
UCB, Inc.7$161
Kyowa Kirin, Inc.8$139
Axsome Therapeutics, Inc.7$123
Ironshore Pharmaceuticals Inc.5$120
Johnson & Johnson7$111
Tanabe Pharma America, Inc.3$83
Banner Life Sciences, LLC4$74
SK Life Science, Inc.3$73
Eisai Inc.4$70
AstraZeneca3$56
Supernus Pharmaceuticals, Inc.3$50
Corium, LLC4$49
Collegium Pharmaceutical, Inc.2$48
Grifols USA, LLC2$46
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$45
Acadia Pharmaceuticals Inc2$39
Amylyx Pharmaceuticals, Inc.2$38
Upsher-smith Laboratories LLC2$35
Jazz Pharmaceuticals Inc.2$34
Neurelis, Inc.2$34
Lilly USA, LLC2$32
EMD Serono, Inc.2$31
Mallinckrodt Hospital Products Inc.2$31
Amgen2$28
Merck2$27
Takeda Pharmaceuticals U.S.A., Inc.2$23
CSL Behring1$21
Harmony Biosciences LLC1$20
Genentech USA, Inc.1$20
Argenx US, Inc.1$18
Biohaven Pharmaceutical Holding Company Ltd.1$14
E.r. Squibb & Sons, L.L.C.1$14

How this compares

$7,139 in reported general payments places this provider in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$15,403
Medicare patients
75
Services billed
183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatric/mental health in Indiana

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →